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In 2005 the Health Research Board continued to deliver successful 
results in line with the objectives set out in the Corporate Strategy 
2002–2006:
n	 To encourage the creation and application of knowledge for health and 
social gain, the growth of intellectual property and evidence relevant to 
health and social gain and the emergence of a knowledge-based health 
system, economy and society
n	 To be the lead national organisation in relation to support for 
scientific research for health and social gain, including basic and 
translational research, health services research, population health 
and practice-based research
n	 To promote the growth of a value-added research and development 
capability in the health system, in partnership with other relevant 
health organisations
n	 To impact on health and social policy and services through high-quality 
research and information
n	 To be the main advocate for the development of research for health and 
social gain
n	 To make the HRB an employer of choice in its field
Mission
To improve health through research and information
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An increase of almost a third in the annual 
revenue grant from the Department of 
Health and Children meant we were able 
to consolidate programmes of support for 
research. In addition to this, Ms Mary 
Harney TD, Tánaiste and Minister for 
Health and Children agreed to support the 
HRB five-year Investment Programme for 
Research for Health and Wealth. This meant 
that for the first time, the HRB could plan 
investments to build health research capacity 
in the medium term. 
A major objective of this investment 
programme is to build world-class capacity 
in health research, particularly in the 
clinical area. Ireland has the potential to 
make a significant contribution at global 
level to clinical research that will improve 
patient outcomes. However, this can only 
take place if the necessary investments are 
made to support people to do the research, 
funding is available for their programmes 
of research and they have access to state of 
the art facilities and equipment needed to do 
research at the cutting edge. 
During 2005 investments under 
this programme were made with the 
appointment of the first two Irish clinician 
scientists, the establishment of a national 
imaging centre for health research at St 
James’s Hospital, and support for the 
purchase of ultra-sound equipment in all the 
major maternity hospitals. This equipment 
will be used to screen expectant mothers to 
understand the causes of low-birth weight 
babies. We were pleased that the Industrial 
Development Authority agreed to work 
with the successful principal investigators 
on these infrastructure projects to maximise 
the impact of the HRB investment with the 
multi-national imaging industry.
The HRB was particularly pleased to 
appoint the first two Irish clinician scientists 
and support their research programmes to 
the value of €3 million over five years. The 
objective of the awards is to enable some 
of our best clinicians to focus on research 
while still retaining a small clinical service 
responsibility. I am confident that the award 
recipients, Dr Joe Keane in TCD/St James’s 
Hospital and Dr Mary Cannon, RCSI/ 
Beaumont Hospital will make a major 
contribution to advancing knowledge in 
their respective fields of respiratory disease 
and mental illness as a result of these awards.
The HRB also participated in or supported 
a number of initiatives that we know will 
have positive results in the near future. The 
most significant was perhaps the partnership 
with the Wellcome Trust and other funding 
bodies in the UK to provide support for 
world-class clinical research facilities that 
Chairman’s Statement
The year 2005 was a time for consolidation and 
preparation at the HRB.
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will benefit human health. The Wellcome 
Trust/HRB call was issued in July 2005 and 
results are expected in the middle of 2006.
The HRB welcomes recognition by the 
economic development agencies – Forfás, 
IDA and Enterprise Ireland - of the strategic 
significance of health research and of the 
Investment Programme in Research for 
Health and Wealth in the context of their 
objective of building national research and 
development capacity. HRB has worked 
closely with these agencies and the other 
research funding bodies to develop a 
framework to support commercialisation 
of knowledge from research to enhance 
Ireland’s knowledge economy and society. In 
this context, the HRB welcomed the decision 
of the newly appointed Science Advisory 
Council to undertake a review of health 
research to establish the critical steps needed 
to strengthen health research capacity
in Ireland.  
The HRB also worked closely with the 
Department of Health and Children to 
prepare the submission on health for the 
draft Strategy for Science, Technology and 
Innovation, which will form an important 
building block of the next National 
Development Programme. The HRB stressed 
the potential in this country to develop 
world-class research in health research, 
in experimental or translational research 
and clinical research in particular as well 
as to the contribution of research and high 
quality information to improve the quality 
of the health system. The Strategy will be 
published next year.
The legislation establishing the Health 
Service Executive gave it a mandate to 
develop a strong research function in the 
health service, which the HRB welcomes. 
To acknowledge the common interest of the 
HRB and the HSE in developing a strong 
culture of research in the health service, the 
HRB hosted a joint meeting of the boards 
of the HRB and the HSE in October to hear 
a lecture from Professor John Williams, 
Director of Research and Development in 
the Welsh health service on the challenge to 
developing a strong health research culture 
in Wales. 
The Board was pleased that the CEO, Dr 
Ruth Barrington, was appointed to the 
Board of the interim Health Information 
and Quality Agency, which was established 
during the year. The interim board has a 
mandate to prepare for the appointment 
of the permanent authority, which will 
be responsible for improving the quality 
of health and social care, the governance 
of health information systems and health 
technology assessment. 
I would like to thank Dr Don Thornhill 
and the members of the international panel 
who reviewed the operation of the HRB 
on an organisation wide basis in 2005. 
Their analysis of the environmental factors 
shaping the HRB, their understanding 
of HRB strengths and their stretching 
recommendations for the future 
development of the organisation were 
invaluable and will form an agenda for 
change in the HRB in the coming year.
The ongoing support and dedication 
of my fellow Board members must be 
acknowledged. As part of their commitment 
to excellence and in the context of the wider 
review of the organisation of the HRB, the 
Board in 2005 reviewed its operations to 
ensure that it was contributing maximum 
value to the achievement of objectives of the 
HRB. The review highlighted a number of 
ways that the Board could maximise impact 
with the time they have available and some 
changes were made to ensure the Board 
focus more on strategy and policy. 
The commitment and professionalism of the 
staff of the HRB was demonstrated yet again 
in 2005. I would like to thank them for their 
hard work and support during the year and 
look forward to working with them again in 
2006.
Professor Desmond Fitzgerald, FRCPI
Chairman
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Mary Harney TD, Tánaiste and Minister for 
Health and Children, agreed to make €50 
million in capital available for an investment 
programme in research for health and 
wealth over five years, beginning in 2005. 
This was in addition to a significant increase 
in the Department of Health and Children’s 
annual revenue grant to the HRB. These 
increases allowed the HRB to increase the 
volume and range of its support for research 
and information systems. 
A decisive step was made to partner the 
Wellcome Trust in the Clinical Research 
Initiative for the United Kingdom and 
Ireland. This will help meet a major long-
term objective of the HRB to establish a 
network of clinical research centres which 
will link the university medical schools and 
their academic hospitals in undertaking 
research that will improve outcomes
for patients. 
The appointment of the first two HRB 
clinician scientists also marked a major 
advance in strengthening capacity in clinical 
research. The HRB is committed to funding 
many more of these posts, but is constrained 
by the existing terms of the current medical 
consultant contract and the long delays in 
agreeing changes to that contract.
Medical education was the centre of 
attention in 2005. I was a member of 
the Postgraduate Medical Education 
and Training Group, chaired by Dr Jane 
Buttimer, which reported during the year. 
The recommendations of the Buttimer 
Report have significant implications for 
the training of medical graduates, and 
for the way in which the HRB currently 
supports those who are committed to 
gaining expertise in research. The Report 
recommends that the HRB support 
structured PhD programmes. The 
publication of the Report coincided with 
an evaluation of the HRB clinical research 
fellowship programme by a review group 
established by the Board. The work of this 
group is leading to significant changes in the 
way HRB supports clinical research training 
for medical graduates.
A highlight of the year was the HRB-
sponsored lecture, ‘It takes two to tango’, 
delivered at the Royal Irish Academy in 
February by Professor Jonathan Lomas, 
director of the Canadian Health Services 
Research Foundation. The subject of the 
lecture was knowledge brokering – bringing 
policy makers and researchers together. 
Professor Lomas gave examples of how 
knowledge brokering between health policy 
Chief Executive’s Report 
The Health Research Board had a highly productive year 
in 2005. 
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makers and researchers operates in his own 
organisation in Canada, indicating both 
the challenges and the rewards in building 
contacts between these two groups.
The HRB and the Northern Ireland R&D 
Office published a consultation paper on the 
proposed all-island GeneLibrary, which will 
be a vital resource for researchers. Under 
this proposal, 10,000 volunteers on the 
island of Ireland would agree to contribute 
their medical history and a blood sample for 
the purposes of establishing a unique control 
sample of the population. Once information 
from the medical history and the blood 
sample are matched, the record would 
be irreversibly anonymised. Consultation 
with the research community began with 
a seminar which examined the value and 
scope of the proposal, and was still in 
progress as the year ended. 
The HRB is committed to supporting 
research on global health challenges, 
particularly on poverty-related diseases that 
take such a toll of human life in developing 
countries. The HRB was pleased to agree a 
Memorandum of Understanding with Irish 
Aid whereby the HRB will organise calls 
to the research community for proposals 
linked to objectives of Irish Aid. The HRB 
will administer these awards and Irish Aid 
will fund the programme. The first Global 
Health Research awards will be made 
in 2006. 
During the year, the HRB played a 
significant role in co-ordinating policies 
and operations among research funding 
bodies and economic development agencies. 
The Research Funders’ Forum is helping 
to increase coherence among the research 
funding bodies. The HRB was also involved 
in an initiative led by Enterprise Ireland 
to develop the agreed framework for 
commercialisation of intellectual property 
funded jointly by industry and public bodies. 
I joined the Medical Technology Council 
established by the Irish Medical Devices 
Association to assist in co-ordinating efforts 
to support a research-friendly environment 
for the development of medical devices.
The HRB continued to monitor the 
implementation of the EU Clinical Trials 
Directive, and expressed its concern to the 
Department of Health about the difficulties 
the implementation of the national 
regulations was causing for clinical trial 
activity in Ireland.
At European level, I chaired the working 
group of the European Strategy Forum 
charged with developing a priority list 
of research infrastructures for biology 
and medical science to be included in 
the first European roadmap for research 
infrastructure, which will be published in 
October 2006. This list was presented to 
the Commissioner in April 2005 and was 
later included in the Commission’s proposals 
for the Seventh Framework Programme, 
the European Union’s main instrument for 
funding research and development, that 
were subsequently adopted by the Council 
of Ministers.
The research and information programmes 
which are conducted at the HRB had a 
number of successes in 2005:
n The HRB was invited by the Government 
to develop and maintain a Drug-Related 
Deaths Index. 
n The HRB published the first report 
from the National Physical and Sensory 
Disability Database, providing the first 
comprehensive information on the 
services requirements of the population 
with such disabilities. 
n The HRB launched the first study of 
levels of psychological stress in Ireland. 
n The HRB undertook to commission 
research studies on the impact of 
demographic change on demand for 
health services and on a resource 
allocation model for the Irish 
health system. The research will be 
commissioned in partnership with the 
Health Service Executive. 
n Based on its extensive research on the 
role of folic acid in preventing neural 
tube defects in children, the HRB made 
a submission to the National Committee 
on Folic Acid Food Fortification strongly 
recommending that the Government 
make it mandatory to fortify staple 
foods such as flour with folic acid at 
a level that international research has 
shown to be effective in preventing these 
devastating disabilities in children. 
A major challenge for the HRB in 2005 
was the review of the entire organisation 
to establish the extent to which it was 
delivering on the objectives of the corporate 
strategy 2002–2006 and to help formulate 
a programme of quality improvement for 
the future. 
The review involved a self-assessment 
exercise against a European standard, 
stakeholder and staff surveys, a review by 
the Board of its performance, and a visit 
over three days by a panel of national 
and international experts in research 
funding, health information systems and 
organisational development. The panel’s 
report confirmed the HRB’s success in 
achieving its corporate objectives but 
commented on the urgent need for a new 
strategy to adapt to the rapidly changing 
external environment. It recommended 
significant changes in the way the 
organisation is structured to enable the HRB 
to cope better with the challenges facing it.
I would like to thank the members of the 
Board and the staff for the enthusiastic 
manner in which they embarked on this 
innovative and demanding review project. 
I am most grateful to the members of 
the external panel, chaired by Dr Don 
Thornhill, for the skill and expertise that 
they brought to the task of assessing 
the performance of the HRB and 
making recommendations for the future 
development of the organisation.
I would like to extend my thanks and 
appreciation to the Chairman, Professor 
Desmond Fitzgerald, and to the members of 
the Board for their excellent leadership of 
the organisation and for their commitment 
to developing the capacity of the HRB to 
support research and information systems of 
the highest quality. 
Ruth Barrington PhD
Chief Executive
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Research funded by the HRB
The HRB funding allocation from the 
Department of Health and Children 
increased in 2005. Capital funding 
of €50 million was also committed by the 
Department for the period 2005–2009 
to support the Investment Programme in 
Research for Health and Wealth. This meant 
that the HRB was well placed to support 
capacity building and infrastructure. 
The HRB proposes to use this additional 
funding in a strategic way to strengthen 
clinical research and build research and 
development capacity in the health system. 
The aim is to harness research to produce 
better patient outcomes and improved 
health in the population. Initiatives funded 
will also contribute to more effective and 
marketable diagnostics, pharmaceuticals and 
information technologies.
New and innovative awards were introduced 
throughout the year to meet these objectives. 
Awards worth €3 million were made to 
clinician investigators – medical consultants 
who focus on world-class research in areas 
that will have direct benefits for patient care. 
There was additional investment to support 
research programmes directly linked to the 
objectives of the health service. Further 
funding was also allocated to increase 
national capacity in imaging equipment for 
health research and to develop an initial 
proposal for an all-island GeneLibrary 
which will contain a large body of samples 
for genetic research.  
The HRB continued to support existing 
grant programmes that have proven 
successful and yielded excellent results. 
A new research funding online newsletter, 
Research Funding News, was introduced, 
which features detailed information about 
upcoming programmes and success stories. 
Funding awarded
Funding provided under science for health 
supports investigator-led research in the 
health, life and social sciences that improves 
our understanding of health and disease and 
contributes to the discovery of improved 
therapies. The HRB provided 108 research 
awards across nine schemes in 2005 from a 
total of 598 applications received. A further 
107 awards were made to build capacity 
through student summer schemes and 
science writing workshops.
A total of 125 peer-reviewed publications 
based on HRB funded research were 
published in 2005.
A number of other successful initiatives were 
also supported.
HRB scholars were literally climbing 
walls to celebrate the success of their PhD 
training schemes and the announcement 
that the HRB will provide additional 
funding to develop new HRB scholar sites 
for PhD training. The decision to underpin 
the new sites was based on a successful 
evaluation of an existing HRB scholar site 
in Trinity College Institute of Neuroscience.  
Institutions will be invited to apply in 2006 
to establish HRB scholar sites which will 
focus on biomedical and clinical sciences, 
health services research or epidemiology and 
public health.
CASE STUDY
New links between medical research 
and patient care
The new awards to support medical 
consultants in undertaking world-class 
research in areas that have direct benefits 
for patient care are the first of their kind 
in Ireland. Two awards, worth a total of 
€3 million, were presented to the new 
Clinician Scientists by the Tánaiste and 
Minister for Health and Children, Mary 
Harney, in May 2005. Both recipients are 
consultants who have developed a strong 
research interest in their specialised field, 
guided by their experience of patient care 
and the most recent information about 
emerging trends. 
Dr Mary Cannon, a senior lecturer in 
RCSI and a consultant in Beaumont 
Hospital, will investigate the onset 
of schizophrenia in young adults. 
The project will monitor the brain 
development of at-risk young adults 
using a variety of imaging techniques and 
psychological assessments with a view to 
improving early detection and prevention.
Dr Joe Keane, a consultant in respiratory 
medicine at St James’s Hospital in Dublin, 
will focus on new ways to prevent and 
treat tuberculosis. This is a chronic lung 
disease, which claims the lives of two 
million people worldwide each year. The 
incidence of this disease has increased in 
Ireland since 2003. 
Speaking at the launch of the awards, the 
Tánaiste said that, to realise the benefit of 
the millions invested by the Government 
in research in the life sciences, in 
biotechnology and in developing this 
country’s research infrastructure, we must 
improve links between the laboratory and 
the delivery of patient care. She believes 
that these awards will succeed in forging 
these links, as well as in raising the profile 
of Irish health research and improving 
patient outcomes. 
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Dana Kilroy and Kevin Murphy, 
Institute of Neuroscience TCD
Prof Des Fitgerald, Chairman, HRB, Dr Mary 
Cannon, RCSI, Dr Joe Keane, St. James's Hosptial
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The third issue in the HRB’s Picture of 
Health series, A Picture of Health: A 
selection of Irish health research 2005, was 
published during the year. Building on the 
success of past issues, it effectively promoted 
the key research outcomes from the project 
grants completed during the year. This 
popular presentation of research findings 
continues to help make health research 
relevant to a broader audience.
Participation in the BA Science Festival 2005 
was a further opportunity to bring health 
research issues to the general public. The 
HRB joined forces with the British Council 
to host a public debate on alcohol, Sláinte: 
To our good health? An expert panel from 
around Europe, chaired by Brian Dobson 
from RTÉ, posed questions such as: Has 
our culture of hard drinking spun out of 
control? if so, should we be concerned? 
Can taking alcohol in moderation be 
good for your health? The lively debate 
included participation by the audience of 
industry experts, researchers, public health 
representatives and the general public.
Funding offered under R&D for health is 
targeted at developing a structure within 
the health system to support research 
and development that will encourage the 
application of knowledge to health problems 
and increase the effectiveness of the health 
system in achieving its goals. Given the 
changes under way in the HSE in 2005, 
it is important to build new relations and 
continue to keep the support for research 
active in the health services.
Based on the success of the Health Services 
Research and Development awards in 
2004, a second call was issued to encourage 
further capacity building in R&D within 
the health services. A total of 27 proposals 
were received and five awards were made 
for projects that are specifically linked to the 
goals and priorities of the health strategy.
Working in co-operation with the Medical 
Research Charities Group (MRCG), the 
HRB launched a new scheme to help tackle 
rare disease. A total of €600,000 will be 
awarded to three research fellows to help 
increase knowledge and build research 
capacity, leading to improved treatment and 
care for people suffering from a rare disease 
in Ireland. Rare diseases are classified as 
life-threatening or chronically debilitating 
diseases that affect fewer than five people 
in every 10,000. Examples of rare diseases 
in Ireland are cystic fibrosis, muscular 
dystrophy and epidermolysis bullosa.
The HRB also signed a Memorandum 
of Understanding with Irish Aid to work 
collaboratively to support global health 
research and to increase research capacity 
in developing countries. This award scheme 
aims to generate high-quality research 
evidence directly related to the policy areas 
of the Irish aid programme and to build 
research capacity in developing countries. 
It will promote international partnerships 
in global health research, with particular 
emphasis on collaborative projects involving 
Irish research institutions.
Evaluation of research programmes
Evaluation is essential to ensure that the 
funding invested meets the objectives and 
achieves value for money. Among the 
reviews carried out by the HRB in 2005 
were the mid-term review of the five-year 
programme grants and progress reviews 
of the PhD scholar sites and the career 
development schemes, with a special 
focus on the clinical research training 
fellowship scheme. A working group is 
being established to consider detailed 
recommendations following the review of 
the clinical research training fellowship 
scheme.
Review of ICORG 
Since 2002, the HRB has invested  
€9 million in building a strong 
infrastructure for clinical trials in ten 
hospitals, all members of the All-Ireland 
Cooperative Group.
Table 1 Summary of funding awarded in 2005
Award schemes 2005 No. of applicants No. of awards
Career support schemes 
Clinician Scientist Awards 13 2
PhD Training Sites 17 2
Post Doctoral Fellowships  45 8
Clinical Research Training Fellowships 43 8
Fellowships in Health Services Research 24 4
Clinical Research Fellowships in Nursing and Midwifery 19 4
NCI Summer Curriculum 20 17
Cancer Prevention Fellowship 1 1
Cochrane Fellowships 10 6
Summer Students 117 46
Research grants
Project Grants – General 310 75
Programme Grants 36 3
Partnerships Awards 23 10
Strategic R&D Awards 27 5
Rare Diseases Research Awards  7 3
Infrastructure 
Imaging Awards 5 2
Health Information Systems Awards 20 6 
Training and workshops
HRB / British Council science writing workshops  101 60
Grant writing workshops 150 150
Cochrane three-day course on systematic reviews 73 39
Total 1061 451
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An additional €0.6 million was awarded in 
the form of a planning grant to ICORG, the 
Irish Clinical Oncology Research Group. 
ICORG acts as a central support office 
for the All-Ireland Cooperative Group 
of hospitals, supporting the initiation 
and conduct of cancer clinical trials in 
the hospitals and working with Irish 
investigators and organisations worldwide 
to increase the number of clinical trials 
available to cancer patients across the island.
During 2005, all components of the 
All-Ireland Cooperative Group were 
assessed, including trial activity in the 
hospitals and progress made with the 
planning grant application to ICORG for 
centralised support. The assessment panel 
acknowledged that ICORG had made 
progress in a number of areas and suggested 
that the group increase the number and type 
of trials available to cancer patients across 
the country. ICORG conducted a review 
and will deliver a response in early 2006 
outlining their actions to tackle the changes 
proposed by the panel. 
Annual Report 2005
Building capacity for health research
In 2005, the HRB led a number of support 
schemes for researchers and health 
professionals and provided seminars and 
courses to build capacity by supporting 
careers, training and infrastructure.
A new call was issued for four career 
development schemes which will be funded 
in 2006. Applications have been submitted 
and are currently undergoing peer review.
Science writing workshops continued to be 
popular. They help researchers develop skills 
in writing up their research in an effective 
way. One workshop this year was hosted 
with the British Council and the other with 
the national Alimentary Pharmabiotics 
Centre in University College Cork.
In an innovative approach to developing 
research capacity in the health services, 
the HRB hosted a series of workshops for 
people interested in doing such research. The 
purpose of these workshops was to highlight 
funding opportunities and to provide advice 
on how to apply successfully for funding. 
The Cochrane collaboration began to pick 
up pace with the launch of another call for 
Cochrane fellowships, a series of three-day 
courses on conducting systematic reviews, 
and preparations for the World Cochrane 
Colloquium in Dublin in 2006. Irish 
researchers continued to enjoy the benefits 
of free access to the Cochrane Library with 
124,255 users in 2005.
Working in partnership
A new working relationship was formed 
with INSERM, the French health research 
agency. Initial meetings resulted in a survey 
being conducted of all collaborations 
between researchers funded by the HRB 
and researchers in France. Initiatives being 
considered for 2006 include setting up an 
exchange programme between the two sets 
of researchers.
 
The Ireland–Northern Ireland–National 
Cancer Institute Cancer Consortium. 
Calls were developed and advertised for 
joint research fellowship schemes, the 
cancer prevention fellowship scheme and 
the summer curriculum in cancer prevention. 
Work continued in endeavour to highlight 
the key challenges to the clinical trials 
network.
The HRB agreed a common approach to 
funding policies in terms of the Protection 
of Employees (Fixed Term Work) Act 
and maternity leave for researchers, in 
collaboration with other agencies through 
the Standing Committee of the Research 
Funding Bodies.
The HRB is working with the Wellcome 
Trust to introduce a major new initiative to 
support key clinical research infrastructure 
in Ireland. The Irish strategy for health 
research, Making Knowledge Work for 
Health, identified clinical research facilities 
as a priority for building health research 
capacity in Ireland. The HRB and the 
Wellcome Trust have a strong track record 
of providing high-quality clinical research 
environments and building capacity.  During 
2005, the HRB and the Wellcome Trust 
invited proposals in two related areas:
n	 The development of new and existing 
clinical research facilities.
n	 Support for enabling technologies/
infrastructure for clinical research.
This is an exciting development for the 
research community and for health in 
Ireland. Results of the peer-review process 
will be announced in July 2006. 
The HRB manages five national information 
systems which provide quality information 
for the planning, monitoring, and evaluation 
of health services disability, drug misuse 
and mental health. These information 
systems also provide an invaluable source of 
information for further research. The HRB 
plays a vital role in the organisation and 
development of the information systems, 
ensuring valid and reliable data, analysing 
and reporting the data and disseminating the 
information to relevant stakeholders. 
The restructuring associated with the 
establishment of the Health Service 
Executive (HSE) presented a new challenge 
for the information systems divisions in 
2005. Data from the previous year had been 
submitted from the original health boards, 
but had to be reported to reflect the new 
structures in place. This challenge was dealt 
with effectively and software was updated 
to reflect and report through the new 
HSE structures.
Some of the major developments in 2005 
included:
National Physical and Sensory Disability 
Database (NPSDD)
The first annual report of the NPSDD 
Committee was published, containing 
information collected in 2004. This data 
was analysed and will be used as an indictor 
to inform service planners of the needs of 
people with physical and sensory disability 
nationwide. 
An action plan was developed in response 
to the evaluation of the NPSDD. This was a 
useful exercise as it brought together various 
stakeholders who identified priorities for 
improvement.
The HRB made significant contributions to 
the publication of international classification 
of functioning and devised the ‘Measure of 
Ability and Participation’. The Economic and 
Social Research Institute will take the national 
aspect of this project to the next stage.
A user manual was developed for telephone 
updating of NPSDD registrations and 
training was provided to people who will 
use the system. 
National Information Systems
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National Intellectual Disability 
Database (NIDD)
The NIDD Annual Report was published 
ahead of schedule, in September, meaning 
that decisions about service provision in 
2006 can be based on the most up-to-date 
information available. Regional bulletins 
were produced to ensure that each HSE 
area could clearly identify key findings and 
requirements for their area. The national 
competition to design the cover of the 
annual report was again an outstanding 
success, with more than 300 entries from 
service users nationwide. The winner was 
Francis Gleeson from Nenagh who is 
actively involved in Ormond Resources, 
where he produces arts, crafts and candles 
as well as painting.
New NIDD software is now installed 
in more than 100 sites. Multiple users 
at each site were supported throughout 
the implementation process and during 
the course of the year.  A documentation 
resource was developed within the NIDD 
software and materials were uploaded 
in December. This means that support 
materials and regional analysis of data will 
be possible for users online.
Throughout the year, training was provided 
to encourage and support the regional use of 
both disability databases and to ensure that 
users could produce reports and interpret 
the information effectively. A protocol was 
introduced for access to these two databases 
at national and regional levels to maximise 
security of information.
National Drug Treatment Reporting 
System (NDTRS)
From the start of the year, existing 
participants in the NDTRS began submitting 
their data for 2005. This will bring the 
records of the databases up to date and will 
mean that the HRB can collate, analyse 
and report on the information gathered in 
the same year. This is extremely useful for 
identifying areas of need and furnishing 
service providers with the most recent 
information available to inform decision 
making.
A proactive approach was taken to 
developing participation in the NDTRS, 
which will help ensure more complete 
datasets. This, in turn, will give a more 
accurate picture of treated drug use 
in Ireland. 
Collection of 2004 data at outpatient, 
inpatient and low-threshold services was 
almost complete by 2005. Following a 
concerted effort to encourage general 
practitioners to participate, significant 
progress was made during the year in 
collecting data for the years 2001 to 2004. 
CASE STUDY
First National Physical and Sensory 
Disability Database Report
The NPSDD was established to ensure 
that information is available to enable 
the Department of Health and Children, 
the HSE and the non-statutory sector 
to provide appropriate services 
designed to meet the changing needs 
of people with a physical or sensory 
disability. The database is intended to 
provide a comprehensive and accurate 
information base for decision making 
in relation to the planning, funding and 
management of services for people with 
a physical or sensory disability and, for 
the first time, to set priorities based on 
an objective evaluation of the needs of 
the population receiving or requiring 
specialised health and personal social 
services.
Progress towards reaching the target 
number of records on the database 
in 2004 was good. From the data it 
is possible to find out the gender, age 
profile, accommodation needs, services 
currently provided and services required 
for the population registered on the 
database. This information is essential 
in planning services for the future.
Prison services will report to the NDTRS 
from 2006 onwards and HRB staff are in 
the process of developing a database to 
facilitate this. Negotiations are under way 
with alcohol services in Dublin, Kildare 
and Wicklow with a view to their providing 
information about people presenting for 
treatment from 2005; these discussions are 
progressing well.
In 2004, an access database was developed 
to enable direct data entry from the centres 
providing a service to people who present 
for treatment for drug misuse. During 2005, 
research analysts, trained data co-ordinators 
and service providers in coding and entering 
the data at source.
Three reports based on information from 
the NDTRS were published during the year. 
These reports looked at trends in treated 
drug use in Ireland from 1998 to 2002. They 
showed that 33,350 people aged between 
15 and 64 years were treated for problem 
drug use in Ireland. The reports compared 
trends in the numbers of cases in Dublin, 
Kildare and Wicklow (the greater Dublin 
area) with those in the rest of the country. 
They revealed that, while the number of new 
cases in the greater Dublin area decreased 
between 2000 and 2002, the number of new 
cases outside this area increased by 300% 
between 1998 and 2002. The reports also 
highlighted the risk behaviours associated 
with drug use, including polydrug use, 
which can lead to overdose, and injecting 
drug use, which is linked to acquiring blood-
borne viruses.
Working closely with key Irish agencies and 
using information from the NDTRS, staff 
helped to address the priority information 
needs in the area of drug misuse in Ireland. 
Staff also had an active role on the National 
Advisory Committee on Drugs.
National Psychiatric In-patient 
Reporting System (NPIRS)
NPIRS data was successfully submitted by 
all in-patient psychiatric units and hospitals 
on a quarterly basis. The HRB provided 
ongoing software support through the 
HRB PAS database, as well as by regular 
liaison with hospital staff who work with 
the system. Promotional efforts continue to 
encourage hospitals and units to submit data 
to NPIRS electronically. 
Data collected by NPIRS was used to 
produce a detailed annual report on all 
psychiatric admissions and discharges 
in Ireland during 2004. As part of a 
customer service initiative, an evaluation 
questionnaire based on the annual NPIRS 
report was included in this year’s report. 
The recommendations arising from this 
survey will be incorporated into future 
publications.
Information from the database was also 
used to produce regional bulletins specific 
to each HSE area twice a year. These help 
to facilitate decision making in relation to 
service provision at a local level.
Performance indicator reports were 
produced for the HSE areas and the 
Department of Health and Children. 
These quarterly reports provide comparable 
data for each local health office (LHO) in 
terms of admission, legal category, diagnosis 
and length of stay of all acute psychiatric 
in-patients in Ireland. 
Community Care Database
In response to changing patterns of patient 
care, the HRB has developed a new database 
called COMCAR, designed to record mental 
health activity at community care level. The 
COMCAR database is now in use at eight 
locations around the country. The database 
has been customised to user needs and 
specific versions have been created for out-
patient clinics, day centres, day hospitals, 
liaison psychiatry and old age psychiatry. 
This work has been crucial in guiding 
ongoing work on the new web-based 
national mental health information system. 
The COMCAR team is working closely 
with the HSE on a pilot project planned for 
Donegal. 
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Child Health
The child health work programme has 
focused around the collaborative research 
programme with the National Institute of 
Child Health and Human Development 
(NICHD) and Trinity College Dublin (TCD) 
on congenital malformations and other 
adverse pregnancy outcomes.  
Based on last year’s groundbreaking research 
that showed the relationship between folic 
acid and risk of neural tube defects (NTDs) 
in pregnancy among the Irish population, 
the HRB made a submission to the National 
Committee on Folic Acid Food Fortification 
to emphasise the importance of fortifying a 
staple food, like flour, with folic acid.
The same findings, which were part of a 
collaborative study with Trinity College 
Dublin and the National Institutes of Health 
in the US, provided the scientific evidence 
for an advertising campaign by the Food 
Safety Authority of Ireland to encourage 
women of childbearing age to take folic acid 
supplements in their diet, whether they were 
intending to become pregnant or not.
Eight papers on related research were 
published in international journals and two 
papers were presented at an international 
meeting on neural tube defects in London.
Mental Health 
Family support study 
A new study was undertaken to explore the 
experiences, needs and support requirements 
of families with direct exposure to mental 
illness. The study involved semi-structured 
interviews with 40–50 people who were 
close relatives of a person with an enduring 
mental illness (defined as an illness lasting 
for more than two years and requiring 
ongoing visits to a mental care service). 
The research aims to find out what supports 
are currently available to families, whether 
families use them, if they are satisfied with 
them, and what other supports are needed. 
This information can then be used to inform 
service providers and policy makers so they 
can design effective services for families 
who support people with illnesses such as 
schizophrenia and depressive disorders.
Psychological distress – do we use services 
or seek help?
A new survey of psychological stress in a 
random sample of the Irish population aims 
to find out how many people suffered from 
psychological distress in the previous 12 
months, whether they availed of a service 
for their problem and whether they would 
be willing to seek help for psychological 
problems in the future. 
Research conducted in-house 
The HRB has commissioned the Economic 
and Social Research Institute to carry out 
the survey by telephone. Results will be 
available in 2006 and it is hoped that they 
will provide sufficient information for 
service planners to design early intervention 
programmes to prevent or reduce 
psychological distress.
Drug Misuse
The illicit drug market
The impact of drug use and drug 
markets can affect people’s physical and 
psychological health. It is important to 
research the potential impact that this can 
have. Examining drug crimes and markets, 
it is possible to identify ways to help disrupt 
drug markets which would in turn reduce 
the potential impact they have indirectly or 
directly on health.
During 2005, the HRB published new 
research on the illicit drug market in Ireland. 
The research pulls together information 
from existing data sources and research 
on illicit drug markets. It identifies trends 
over time and highlights knowledge gaps. 
The research found that the drug market 
continues to grow in spite of huge global 
investment to eliminate it. Based on a 
commonly used estimation that the amount 
of drugs seized represents only 10% of the 
total imported, the combined estimated 
market value in Ireland for cannabis resin, 
ecstasy, cocaine, heroin, amphetamines, 
cannabis and LSD was €650 million in 2003.
The report reviews data from the Garda 
Síochána, the customs authorities, the 
Forensic Science Laboratory and drug users 
themselves. The author concludes that, 
because this data is collected by a variety of 
groups, each for their own purposes, there 
are gaps in the information and a lack of 
consistency in processes. The research points 
to the need for all the data to be complied 
and researched annually in order to improve 
our understanding of how the drug market 
works. This, in turn, would make it possible 
to identify how the market could be 
disrupted and to monitor the effect of law 
enforcement efforts.
 
CASE STUDY 
Drug-related deaths in Ireland
The HRB published the first 
comprehensive overview of drug-related 
deaths in Ireland in June 2005. This 
review, the first issue in the HRB’s 
Overview series, analyses data collected 
from a variety of sources* in Ireland 
between 1990 and 2002. The trends 
identified show a substantial increase in 
drug-related deaths between 1995 and 
2000 from 43 to 119, falling in 2001 to 
88, with a small rise in 2002, to 91. This 
pattern reflects trends in Europe.
To date, deaths as an indirect result 
of drug use are not systematically 
documented and have been assessed only 
in localised studies within Dublin. The 
findings of the Overview indicate an 
underestimation of opiate-related deaths 
in Dublin and a lack of information about 
deaths as a result of other drugs. The 
National Drugs Strategy has identified 
the need for precise information on 
drug-related deaths as a priority area 
for research. For this purpose, the HRB 
was invited during the year to develop a 
National Drug-Related Deaths Index to 
collect and record data on drug-related 
deaths and deaths among drug users.
Work commenced on this initiative 
immediately. The index is an essential tool 
because drug-related deaths and deaths 
among drug users are indicators of drug 
misuse in Ireland. Accurate data will 
help identify the size of the problem and 
will indicate more precisely the causes 
of death. In time, this will allow policy 
makers, service planners and practitioners 
to develop appropriate responses to the 
consequences of drug misuse and to 
monitor the impact of supply and criminal 
justice issues, prevention measures, harm 
reduction intervention and rehabilitation 
responses. 
*Sources for the initial review of drug related deaths 
were the General Mortality Register, studies that had 
extracted data from the Coroners office, the Central 
Treatment List and infectious disease statistics.
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Key research findings, information and 
news on drug misuse were also disseminated 
through the Drugnet Ireland newsletter. Due 
to demand and the growing availability of 
new findings, four issues were published 
during the year.
European research 
The drugs division is a national focal point 
for the European Monitoring Centre for 
Drugs and Drug Addiction (EMCDDA). 
Research and information on the drug 
situation in Ireland is compiled every year 
and sent to the EMCDDA. 
Work is ongoing to: 
n	 Maintain the Irish contribution to 
the European Database on Demand 
Reduction Activities – 10 new projects 
were added to the database in 2005.
n	 Develop the five existing epidemiological 
key indicators of drug misuse with a view 
to improving national data sources and 
increasing the comparability of Irish and 
EU data. 
n	 Collaborate with other focal points 
in the REITOX network on the 
conceptualisation of new indicators of 
drug misuse and the identification of 
new areas for research. Two structured 
questionnaires, on alternatives to 
prison for drug users and on policy and 
institutional frameworks, were finalised 
during the year for inclusion in the 
EMCDDA work plan 2006.
n	 Provide national reports and information 
exchange on the drug situation in Ireland 
to the EMCDDA and help disseminate 
the findings in Ireland.
Disseminating the results of research – The 
National Documentation Centre on Drug 
Use (NDC)
The NDC is a unique information resource 
providing Irish researchers with access 
to electronic and hard-copy research 
documentation on all aspects of drug use. 
It provides valuable support to researchers, 
media and the public.
During 2005 the capacity of the library 
continued to increase:
n	 The website was re-launched to help 
profile the library materials in a more 
user-friendly way.
n	 Compared to 2004 figures, there was an 
18% increase in the number of queries 
received by the NDC, a 75% increase in 
the number of new users and a 100% 
increase in the number of unique visitors 
to the website.
n	 A monthly electronic newsletter on 
the latest work in drug-use research 
was produced and circulated to 216 
subscribers. 
n	 The NDC’s library collection increased 
by 500 volumes. 
n	 The NDC’s information services were 
developed and enhanced to ensure an 
efficient, thorough and well-presented 
delivery of information to the users of 
these services. 
Corporate services underpin the operational 
environment in which staff carry out their 
work, and provide support to the Board. 
Creating the best possible environment will 
lead to greater productivity and a more 
positive employee culture. A major focus 
for all staff in 2005, from a corporate 
perspective, was the organisational review 
(see case study insert). 
Other key achievements are highlighted 
under the headings below.
Finance
In 2005 the Department of Health and 
Children committed €50 million over five 
years to support the HRB’s Investment 
Programme in Research for Health and 
Wealth and the Department’s annual revenue 
grant to the HRB increased significantly.  
The HRB used the additional funding 
available in 2005 to increase the number of 
research awards made and to grant-aid the 
purchase of research equipment and other 
infrastructure.
The internal auditors conducted reviews 
of the research grants administration 
procedures and the value for money 
procedures within the HRB.
Work commenced on the development of 
an online management accounting reporting 
system for implementation in 2006, and 
budgeting and financial planning procedures 
were enhanced.
Information and communications 
technology (ICT)
Work continued on the implementation of 
the HRB’s ICT strategy, which included 
the installation of broadband for all 
teleworkers, a new firewall server with 
improved security, and upgraded antivirus 
software on all computers.  In consultation 
with the HRB’s Partnership Committee, the 
ICT and Internet usage policy was updated.
The development of the functionality of the 
HRB website continued during 2005 and an 
extranet was built to allow the Board and 
members of research award selection panels 
to access relevant documentation online.
Corporate Services
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Facilities
A full review of the HRB’s accommodation 
requirements was conducted during 2005 
and ministerial approval was granted for the 
leasing of larger office accommodation in 
Lower Mount Street and the assignment of 
the HRB’s lease on its offices in Holbrook 
House in Holles Street. Detailed plans 
were drawn up to facilitate the staff move 
scheduled for February 2006.
In addition, Board approval was granted 
for the HRB’s Customer Service Charter, 
reception procedures were reviewed and new 
arrangements were put in place for catering 
for in-house events.
HR and organisational development
Staff performance is linked to a good 
working environment, excellent conditions, 
a positive culture and a good level of 
job satisfaction. The HRB conducted a 
second staff survey in 2005 as part of the 
organisational review. The results of this 
survey will be used as a benchmark to 
measure staff satisfaction over the coming 
years. The survey was completed in June, 
after which focus groups discussed some of 
the specific issues that had been raised. The 
management team completed an action plan 
which was referred to the HRB Partnership 
Committee for comment. The action plan 
will be implemented in 2006.
HR continued to support divisions in 
recruiting and training and in measuring 
performance through established 
best practice. Work continued on the 
implementation of the HR strategy and 
regular reports were submitted to the 
Performance Verification Group to profile 
the main achievements that had been 
made under the key headings highlighted 
in Sustaining Progress. All benchmarking 
payments were received by staff, based 
on ongoing delivery of business process 
improvements and modernisation in all 
key areas. 
Communications
A communications strategy was devised 
to provide direction for a communications 
proactive effort commencing in 2006. The 
strategy identified key target audiences, 
the messages the HRB would like to take 
to them and the means by which this will 
be done. 
 
The communications department 
supported the production of more than 
25 publications, organised five key events, 
facilitated 11 sponsorships and secured 
sustained coverage in the national and 
medical media throughout the year. 
new 
office
CASE STUDY 
In pursuit of excellence
The HRB undertook an organisational 
review in 2005 to establish the extent to 
which the organisation was delivering on 
its corporate strategy and to provide a 
programme of quality improvement for 
the future. The review began early in the 
year with a process of self-assessment 
when, with external facilitation, staff 
rated the performance of their divisions 
and of the organisation in terms of best 
practice. Using the Business Excellence 
Model, they compared performance on 
leadership, policy and strategy, people, 
resources, processes, customer results, 
people satisfaction, society results and 
key performance results. The Board 
undertook a facilitated review of its 
own performance. Staff and stakeholder 
reviews were undertaken by external 
companies.
The outcome of this self-assessment was 
collated into an organisational self-
assessment report. This report was issued 
to an international, external review panel 
in October, along with the detailed results 
of a stakeholder survey and the review of 
the Board. The panel spent three days in 
the organisation in November reviewing 
the working processes and conducting 
interviews with key stakeholder groups. 
The chair of the panel, Dr Don 
Thornhill, Chair of the National 
Competitiveness Council, presented 
the panel’s findings to Board members 
and staff at the end of the third day. 
The panel’s report confirmed the HRB’s 
success in achieving its objectives, but 
emphasised the urgent need for a new 
corporate strategy to adapt to the rapidly 
changing environment in which the HRB 
now operates. The panel reported that 
the organisation had reached a very 
promising stage in its organisational 
development and was well positioned 
to seize opportunities presented by the 
profound external changes in the health, 
research and information sectors. It 
commended the HRB on its performance 
to date, on the respect it had earned from 
stakeholders and on the commitment 
of its staff. The panel recommended a 
number of changes to the structure 
and processes of the HRB to enhance 
its capacity to cope with current and 
future change.
A Quality Improvement Plan (QIP) 
based on the recommendations of the 
review panel will be adopted, and the 
recommendations will have a major 
impact on the shape of the HRB corporate 
strategy for the period 2007–2011. 
22+23
Annual Report 2005
Barron S and Mulvany F (2005) Annual Report of the National Intellectual Disability 
Database Committee 2005. Dublin: Health Research Board. 
National Physical and Sensory Disability Database Committee (2005) Evaluation of the 
National Physical and Sensory Disability Database. Dublin: Health Research Board. 
Galligan K, Doyle A and Mulvany F (2005) Annual Report of the National Physical and 
Sensory Disability Database Committee 2004. Dublin: Health Research Board. 
Health Research Board (2005) NPSDD Notes: An update on the National Physical and 
Sensory Disability Database. Dublin: Health Research Board. 
Kirke PN and Scott JM (2005) Pre-conception nutrition and prevention of neural tube defects. 
In Sadler MJ, Strain JJ, Caballero B, (eds) Encyclopedia of Human Nutrition. 2nd Edition.  
Oxford: Academic Press, Volume 3, 15–27.
Parle-McDermott A, Pangilinan F, Mills JL, Signore CC, Molloy AM, Cotter A, Conley M, 
Cox C, Kirke PN, Scott JM and Brody LC (2005) A polymorphism in the MTHFD1 gene 
increases a mother’s risk of having an unexplained second trimester pregnancy loss. Molecular 
Human Reproduction, 11(7): 477–480.
Molloy AM, Mills JL, Cox C, Daly SF, Conley M, Brody LC, Kirke PN, Scott JM and Ueland 
PM (2005) Choline and homocysteine interrelations in umbilical cord and maternal plasma at 
delivery. American Journal of Clinical Nutrition, 82(4): 836–842.
O’Leary VB, Mills JL, Parle-McDermott A, Pangilinan F, Molloy AM, Cox C, Weiler A, 
Conley M, Kirke PN, Scott JM, Brody LC and Birth Defects Research Group (2005) Screening 
for new MTHFR polymorphisms and NTD risk. American Journal of Medical Genetics, 
138(2): 99–106.
O’Leary VB, Mills JL, Pangilinan F, Kirke PN, Cox C, Conley M, Peng K, Shane B, Scott 
JM, Parle-McDermott A, Molloy AM, Brody LC and Birth Defects Research Group (2005) 
Analysis of Methionine Synthase Reductase polymorphisms for Neural Tube Defects risk 
association. Molecular Genetics and Metabolism, 85(3): 220–227.
Swanson DA, Pangilinan F, Mills JL, Kirke PN, Conley M, Weiler A, Frey T, Parle-McDermott 
A, O’Leary VB, Seltzer RR, Moynihan KA, Molloy AM, Burke H, Scott JM and Brody LC 
(2005) Evaluation of transcobalamin II polymorphisms as neural tube defect risk factors in an 
Irish population. Birth Defects Research. Part A: Clinical and Molecular Teratology, 73(4): 
239–244. 
Parle-McDermott A, Mills JL, Kirke PN, Cox C, Signore CC, Kirke S, Molloy AM, 
O’Leary VB, Pangilinan FJ, O’Herlihy C, Brody LC and Scott JM (2005) MTHFD1 R653Q 
polymorphism is a maternal genetic risk factor for severe abruptio placentae. American Journal 
of Medical Genetics, 132A(4): 365–368.
Publications
Drug Misuse Research Division (2005) Drugnet Ireland. Issue 13, Spring 2005. Dublin: Health 
Research Board.
Drug Misuse Research Division (2005) Drugnet Ireland. Issue 14, Summer 2005. Dublin: Health 
Research Board.
Drug Misuse Research Division (2005) Drugnet Ireland. Issue 15, Autumn 2005. Dublin: Health 
Research Board.
Drug Misuse Research Division (2005) Drugnet Ireland. Issue 16, Winter 2005. Dublin: Health 
Research Board.
Kelly F, Lynn E and Long J (2005) Treatment demand in the Health Service Executive Eastern 
Region, 1998 to 2002. Occasional Paper 15. Dublin: Health Research Board. 
Kelly F, Long J and Lynn E (2005) Trends in treated problem drug use in the Health Service 
Executive Eastern Region, 1998 to 2002. Occasional Paper 16. Dublin: Health Research Board.
Long J, Lynn E and Kelly F (2005) Trends in treated problem drug use in Ireland, 1998 to 2002. 
Occasional Paper 17. Dublin: Health Research Board.
Long J, Lynn E and Keating J (2005) Drug-related deaths in Ireland, 1990-2002. Overview 1. 
Dublin: Health Research Board.
Connolly J (2005) The illicit drug market in Ireland. Overview 2. Dublin: Health Research Board.
Olszewski D, Seppala P, Fotiou A, Pike B, Leibrand S and Feijao F (2005) Youth media. 
EMCDDA Thematic Papers. Lisbon: European Monitoring Centre for Drugs and Drug 
Addiction.
O’Neill C, Kelly A, Sinclair H, Kennedy H (2005) Deprivation: different implications 
for forensic psychiatric need in urban and rural areas. Social Psychiatry and Psychiatric 
Epidemiology, 40(7): 551–556.
Smith SM, Long J, Deady J, O’Keeffe F, Handy D and O’Dowd T (2005) Adapting developing 
country epidemiological assessment techniques to improve the quality of health needs 
assessments in developed countries. BMC Health Services Research, 5: 32. 
 http://www.biomedcentral.com/content/pdf/1472-6963-5-32.pdf 
24+25
Annual Report 2005
Health Research Board
Extract from Financial Statements
Revenue Income and Expenditure Account for the year ended 31 December 2005
   
      
 
 2005 2004
   €  €
   
Income   
Department of Health and Children revenue grant 1,45,000    14,953,000 
Other research funding 1,20,30     1,948,534 
Projects undertaken for the Department of Health and Children 5,505,325   6,058,873
     
Interest receivable 44,36          45,736 
Rental income 53,5          33,887 
     
 26,21,846    23,040,030 
Expenditure   
Research Funding and Policy 16,562,61    13,846,741 
Child Health Epidemiology 62,823     1,094,160 
Drug Misuse Research  1,01,3        824,637 
Mental Heath Research 666,66        498,162 
Disability Databases 426,16        417,966 
R&D for Health  4,4,41     4,327,904 
Administration costs and general overheads 2,351,018     1,983,982 
Pensions paid to retired members of staff (10,84)         30,111 
   
 26,260,06    23,023,663 
   
Surplus for the year 11,140          16,367 
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Capital Income and Expenditure Account for the year ended 31 December 2005
   
   
       
 2005 2004
   €  €
   
Income   
Department of Health and Children capital grant 1,813,08  7,677,490
Other capital income 1,50 -
Amortisation of capital fund account 145,562  142,284
   
 1,60,241  7,819,774
Expenditure   
Equipment grants paid to third parties 1,616,965 7,472,138
ICT development 106,678  113,156
Contribution to fixed assets 81,158  19,235
Maintenance of premises 9,878        72,961
Depreciation 145,562  142,284
   
 1,960,241  7,819,774
   
(Deficit)/Surplus for the year  -                -   
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Health Research Board
Extract from Financial Statements
Balance Sheet as at 31 December 2005
   
      
 
 2005 2004
   €  €
   
Fixed assets    
Tangible assets 381,042  451,083 
    
    
Current assets    
Debtors 24,011  867,215 
Investments 641 641 
Cash at bank and on hand ,56,644  4,724,905 
    
 8,24,26 5,592,761 
    
    
Current liabilities    
Amounts falling due within one year:    
Creditors and deferred income 8,205,333  5,514,938 
    
 8,205,333  5,514,938 
Net current assets 88,63  77,823 
    
    
Net assets 40,005 528,906 
    
    
Reserves    
Accumulated surplus on income and expenditure account        88,63 77,823 
Capital fund 381,042 451,083 
  
 40,005 528,906
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Appendix 1
Participation in national, European and
international groups and committees
The Health Research Board invests a significant amount of time contributing to a wide variety of 
national, European and international bodies. These include:
n European Science Foundation Member Association Group
n The Standing Committee of Research Funding Agencies
n Ad hoc group of European Nurse Research Developers
n HEA Infrastructures Group
n The Research and Development Office, Northern Ireland
n The Institute of Public Health in Ireland
n The Irish Forum on Global Health 
n The Environmental Protection Agency
n Development Cooperation Ireland
n The Irish College of General Practitioners
n The Cystinosis Foundation
n The Medical Research Charities Group
n The Irish Council for Bioethics
n National Intellectual Disability Database Committee 
n National Physical and Sensory Disability Database Committee 
n National Intellectual Disability Database Regional Database Administrators’ Group
n National Physical and Sensory Disability Database Regional Database Administrators’ Group
n National Monitoring Committee overseeing the state investment programme in intellectual  
 disability services
n National Advisory Committee on Drugs – Prevalence, Treatment, Consequences, 
 Early Warning and Emerging Trends sub-committees 
n Health Implementation Committee of the National Drugs Strategy, Department of Health 
 and Children.
n Membership of addiction services performance management group 
n Membership of the drug treatment services in prisons research group
n Membership of the Hepatitis C Scientific Advisory Subgroup of the Blood Borne Virus Forum
n Irish Health Sciences Library Group
n Pompidou Group
n European Monitoring Centre for Drugs and Drug Addiction
n	 EDDRA
n Expert Group on Mental Health Policy 
n Mental Health Advisory Subgroups including - Research and Information Manpower, 
 Education  and Training Mental Health Services for Later Life, Forensic Mental Health   
 Services,  Services for eating disorders, Children and Adolescent Psychiatric Service Working  
 Group Research 
n Advisory Group Membership – National Disability Authority 
n	 Adoption Agency
n Nursing Research Development Group
n Irish Internet Association
n Irish Evaluation Network
n Irish Society of Clinical Research Professionals
n Science Foundation Ireland
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Appendix 2 
New grant holders 2005
Grant holder Title
PROJECTS AND PROGRAMMES
Research Project Grants – General
Dr Catherine Greene
Medicine
Royal College of Surgeons in Ireland 
2216,475.20
Regulation of apoptosis by misfolded Z 
alpha-1 antitrypsin
Mr Ronan Conroy
Epidemiology & Preventive Medicine
Royal College of Surgeons in Ireland
2210,889.40
Can psychological models of mood and 
positive affect inform interventions to 
improve outcomes for individuals with acute 
coronary syndrome?
Dr Dermot Walls
Faculty of Science and Health
Dublin City University
2229,298.40
Role and mechanisms of changes to the 
transcriptome that lead to enhanced cell 
survival during Epstein-Barr virus infection 
and in related malignancies.
Dr Mauro Adamo
Chemistry
Royal College of Surgeons in Ireland
2256,346
Investigating the role of the PGHS-
peroxidase: rational design of a novel 
inhibitor
Professor Kingston Mills
Biochemistry
Trinity College Dublin
2238,333.20
Regulation of T cell responses in immunity 
to Bordetella pertussis
Dr Philip Newsholme
Biochemistry
University College Dublin
2237,796.80
Immune regulation of pancreatic beta cell 
function and integrity in Diabetes
Dr Michael Gill
Psychiatry
Trinity College Dublin
279,077.60
A prospective study of the clinical genetics of 
methylphenidate response in children with 
Attention Deficit Hyperactivity Disorder
Professor Charles Dorman
Microbiology
Trinity College Dublin
2101,203
Regulatory Evolution in a Bacterial Pathogen
Dr Lorraine Kyne
Dept of Medicine and Therapeutics
Mater Misericordiae Hospital
2220,605.70
A prospective study of the incidence, 
outcomes, immune response and 
antimicrobial susceptibility of toxin-variant 
C. difficile.
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Grant holder Title
Professor Walter McNicholas
Respiratory Medicine
University College Dublin
2244,659.60
Cell and molecular mechanisms of car-
diovascular complications in sleep apnoea 
syndrome
Professor James Docherty
Physiology
Royal College of Surgeons in Ireland
2240,694.80
The role of Nitric oxide synthase-2 in the 
development and maintenance of portal 
hypertension
Dr Aideen Sullivan
Anatomy/Neuroscience
University College Cork
2241,403.80
Embryonic stem cells for Parkinson’s disease
Dr Ronan Murphy
Biotechnology
Dublin City University
2168,110
The Role of Lasp-1 Expression and Signaling 
in Cardiovascular Disease
Dr Caroline Herron
Physiology
University College Dublin
2129,432.40
Effect of altered cholesterol and lipid 
metabolism on synaptic plasticity: Possible 
neuroprotective effects in transgenic model 
od Alzheimer’s disease.
Dr Fionnuala McAuliffe
Obstetrics & Gynaecology
University College Dublin
2145,018
Heart function in infants of insulin 
dependent diabetic mothers.
Dr Bernard Mahon
Biology
National University of Ireland, Maynooth
2176,498
The role of CCL28 in human airway 
inflammation
Dr Sally-Ann Cryan
Pharmacy
Royal College of Surgeons in Ireland
2228,354
Targeted siRNA delivery to the lungs for the 
treatment of inflammatory lung disease.
Dr Jana Haase 
Biochemistry
University College Dublin
2245,485.20
Characterisation of serotonin transporter-
associated protein complexes within lipid 
microdomains - a proteomic approach
Dr Maura Grealy
Pharmacology
National University of Ireland, Galway
2231,688.40
A signalling role for desmosomal proteins in 
vertebrate heart development?
Dr Heinz Peter Nasheuer 
Dept. of Biochemistry
National University of Ireland, Galway
2228,400.40
Interactions of Primase with DNA
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Dr James O’Gara
Industrial Microbiology
University College Dublin
2120,944
Characterisation of ica-independent 
biofilm development in methicillin 
resistant Staphylococcus aureus
Dr Aideen Long
Biochemistry
Trinity College Dublin
2248,287.20
CD44 - a pivotal molecule in endothelial 
cell fate?
Professor Jochen Prehn
Physiology and Medical Physics
Royal College of Surgeons in Ireland
2244,722
Molecular analysis of cell death induced 
by defects in protein processing and 
protein degradation in Alzheimer’s disease
Dr Tom Moore
Biochemistry
University College Cork
2105,132
Pleiotrophin-mediated shedding of fetal 
DNA
Dr Yuri Volkov
Clinical Medicine
Trinity College Dublin
2230,930.80
The role of flow dynamics and chemokine-
induced cell polarization in the multi-step 
leukocyte navigation
Dr Deirdre Hurley
Faculty of Medicine and Health Sciences
University College Dublin
2135,298
Irish medical practitioners attitudes and 
beliefs to chronic low back pain
Professor Gerald O’Sullivan
Cork Cancer Research Centre
University College Cork
2240,756.80
Long-term, systemic antitumour immunity 
via local, non-viral gene therapy of 
malignant  tumours.
Dr Declan Gilheany
Chemistry
University College Dublin
2229,745.20
Libraries of Modified Sugars for 
Anticancer and Antimicrobial Studies
Dr Neil Rowan
Biological Science
Athlone Institute of Technology
2113,134
Disinfection and sterilisation of medical 
instruments, devices and contact surfaces 
using novel electrotechnologies
Dr Kieran McDermott
Anatomy-Neuroscience
University College Cork
2216,554.40
Role of neuroepithelial stem cells in 
development and repair.
Grant holder Title
Dr Catherine Comiskey
Mathematics
National University of Ireland, Maynooth
272,176
An analysis of the drug using career and 
its impact on prevalence and incidence of 
drug use in Ireland
Professor Cliona O’Farrelly
Education & Research Centre, S.V.U.H.
Trinity College Dublin
2237,586
Investigation of KIR genotype in the 
resolution of HCV infection
Professor Finian Martin
Pharmacology
University College Dublin
2150,000
A role for JNK in supporting adhesion 
molecule expression in mammary 
epithelial cell 3D-acinar assemblies
Professor Noel Lowndes
Biochemistry
National University of Ireland, Galway
2253,156.80
Biochemical characterisation of 53BP1, 
a putative RAD9 orthologue
Dr James Jones 
Human Anatomy and Physiology
University College Dublin
29,900
Mechanism of laryngeal sensing of expired 
carbon dioxide
Professor Desmond Fitzgerald
Molecular Medicine
University College Dublin
2234,344.40
Identifying the protein targets of the 
anti-inflammatory prostaglandin J2
Professor Martin Kinirons
Oral Health Services Research Centre
University College Cork
2146,549.60
Improving the Efficiency of Dental 
Screening with Respect to Fissure Sealing
Professor Luke O’Neill 
Biochemistry
Trinity College Dublin
2229,298.40
A polymorphism in the gene encoding 
the Toll - IL-1 receptor adapter Mal that 
protects against infection
Dr Carmel Breslin
Chemistry
National University of Ireland, Maynooth
2217,381.20
A Novel Drug Delivery System Using 
Conducting Polymers
Dr Ursula Fearon
Rheumatology
University College Dublin
2130,274
A-SAA regulates cytoskeletal 
rearrangement and cell matrix interactions 
topromote cell migration and cartilage 
invasion in inflammatory arthritis ?
Dr Julie Kelly
Biochemistry
Trinity College Dublin
2238,702.80
Furthering the development of potent 
thyrotropin-releasing hormone-degrading 
ectoenzyme (TRH-DE) inhibitors – toward 
a novel therapeutic for CNS disorders
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Professor Tom Cotter
Biochemistry
University College Cork
2237,464.40
Identification and biological 
characterisation of novel anti-apoptotic 
compounds for the potential treatment of 
retinal degeneration: in vitro and in vivo 
studies
Professor John Joseph Morrison
Obstetrics & Gynaecology
National University of Ireland, Galway
2126,427
Human Uterine Mitochondrial K-ATP 
Expression and Modulation
Dr John Laffey
Department of Anaesthesia
National University of Ireland, Galway
2223,717.20
Oxidant Stress, Hypercapnia and Acute 
Lung Injury: From Mechanistic Insights to 
Therapeutic Strategies
Professor Edward Johns
Physiology
University College Cork
2222,465.60
Oxidative stress in the kidney:  
interactions of superoxide anions and 
nitric oxide on fluid reabsorption at the 
proximal tubule
Dr Aidan Bradford
Physiology and Medical Physics
Royal College of Surgeons in Ireland
214,888.40
Does oxidative stress contribute to 
impaired respiratory muscle function 
following chronic episodic hypoxia?
Dr Paul Moynagh
Pharmacology
University College Dublin
2167,220
Exploring human SEF as a regulator of 
Toll-like Receptor Signalling
Dr Ciaran Morrison
Biochemistry/ NCBES
National University of Ireland, Galway
2218,642.40
Molecular mechanisms of DNA damage-
induced centrosome amplification
Dr Ziarih Hawi
Genetics
Trinity College Dublin
2240,220.80
Noradrenergic System Candidate Genes 
in an Irish ADHD Population: Linkage 
Disequilibrium Mapping (LD) and Refined 
Neuropsychological Phenotypes
Dr Paul Cotter
Microbiology
University College Cork
2118,415
Activity of the lantibiotic, lacticin 3147, 
against vancomycin resistant enterococci 
(VREs) and methicillin resistant 
Staphylococcus aureus (MRSAs)
Dr Susan Smith
Department of Public Health and Primary Care
Trinity College Dublin
2234,660.20
Improving Outcomes in Type 2 Diabetes 
Across the Primary-Specialty Care 
Interface: A Brief Family Intervention
Dr Padraig Strappe
Regenerative Medicine Institute
National University of Ireland, Galway
2221,065.20
Lentiviral Vector Delivery of siRNA and 
Neurotrophic Growth Factors for the 
Treatment of Injury to the CNS
Grant holder Title
Dr Gianluca Pollastri
Computer Science
University College Dublin
2156,600
New models for the prediction of 
Quantitative Structure-Property 
Relationships of chemical compounds
Professor Kay Ohlendieck
Biology
National University of Ireland, Maynooth
2168,640
Role of the dystrophin-glycoprotein 
complex and associated regulatory 
elements in non-obese type 2 diabetic 
skeletal muscle
Dr Rosemary O’Connor
Biochemistry
University College Cork
2127,993
Function of Mystique in epithelial cell 
migration and in cancer progression.
Dr Birgit Greiner
Epidemiology and Public Health
University College Cork
2252,666
The Effects of the Smoking Ban in Ireland: 
Smoking Prevalence, Respiratory Health 
and Smoking Risk Perception.
Professor David Coleman
Oral Surgery, Oral Medicine and Oral 
Pathology
Dublin Dental School and Hospital
2230,084.40
The role of cell wall di-tyrosine in 
Candida albicans: potential novel 
antifungal drug targets
Professor Hannah McGee
Department of Psychology
Royal College of Surgeons in Ireland
2182,587.20
Alcohol and unsafe sex in young Irish 
adults: Understanding their complex 
interaction in a general population sample
Dr Angus Bell
Microbiology
Trinity College Dublin
2228,914.40
Inhibition of the terminal stages of host 
haemoglobin degradation by malarial 
parasites: a new approach to antimalarial 
therapy?
Dr Walter Cullen
Department of General Practice
University College Dublin
2119,377.20
Prevalence of problematic alcohol 
consumption among current or former 
heroin users attending general practice: a 
cross sectional survey
Dr Anne Parle-McDermott
School of Biotechnology
Trinity College Dublin
2251,924.90
Folate Polymorphisms: gene expression, 
haplotypes and disease risk
Dr Anne MacFarlane
Dept of General Practice
National University of Ireland, Galway
2169,343
Patients’ perspectives of continuity of 
care in general practice out of hours co-
operatives: A combined methods study
Professor Finbarr O’Sullivan
Statistics
University College Cork
2235,829.36
Statistical Methods for Quantitative 
Dynamic PET Imaging Studies with 
Extension to MR and CT
34+35
Annual Report 2005
Grant holder Title
Dr Evelyn Murphy
Biochemistry and Physiology
University College Dublin
2123,412
Elucidating the molecular mechanisms of 
methotrexate action
Dr Orina Belton
Molecular Medicine
University College Dublin
2246,617.20
The anti-atherogenic activity of CLA 
isomers
Dr David Finn
Department of Physiology
National University of Ireland, Galway
2236,679.20
Elucidating the role of the 
endocannabinoid system in fear-
conditioned analgesia
Dr Ciaran Simms
Mechanical Engineering
Trinity College Dublin
2201,154
Numerical and Experimental Analysis of 
Wheelchair and Occupant Crash Safety
Dr Jane Ann Irwin
Veterinary Physiology and Biochemistry
University College Dublin
2120,760
The mucinase system in the lung - the key 
to mucus degradation?
Dr Yvonne Birney
Vascular Health Research Centre
Dublin City University
2121,404
Notch-mediated Migration of Vascular 
Smooth Muscle Cells
Professor Cecily Kelleher
Public Health Medicine and Epidemiology
University College Dublin
2241,944.50
Prospective follow-up of Lifeways Cross-
Generation Cohort families
Dr Helen Whelton
Oral Health and Development, Oral Health 
Services Research Centre
University College Cork
2251,185.20
Dental Erosion in Irish Teenagers: 
An Epidemiological and Laboratory 
Investigation
Dr Veronica Campbell
Physiology
Trinity College Dublin
2148,574
Tissue engineering of cartilage and bone in 
a hypoxic environment
Dr Michael P. Carty
Biochemistry
National University of Ireland, Galway
2232,892.80
The role of DNA polymerase eta and 
Fanconi anemia D2 protein in the cellular 
response to cisplatin and mitomycin C.
Dr David Henshall
Physiology
Royal College of Surgeons in Ireland
2258,710
Role of Bcl-2-interacting mediator of cell 
death in seizure-induced brain injury and 
epileptogenesis
Grant holder Title
Dr Mary McCaffrey
Biochemistry
University College Cork
2235,574
A functional molecular and cellular 
analysis of Haemochromatosis
Partnership Awards
Dr Sinead McGilloway
Department of Psychology
NUI Maynooth
260,000.00
Health promotion in palliative care: 
identifying and responding to attitudinal 
barriers to service use
Maeve Martin
Community Care Psychology Department
HSE South East 
229,040.00
The epidemiology of psychiatric disorders 
in children and adolescents in Clonmel: An 
interview study following a preliminary 
Child Behaviour Checklist screening of a 
population of 3000 youngsters
Hilary Dunne
Research Department
Irish Society for Quality & Safety in Healthcare 
260,000.00
Healthdata –Are there benefits to 
multidisciplinary collaboration for the 
development of an All-Island research 
information database on health initiatives
Margaret Leahy 
Clinical Speech and Language Studies
Trinity College Dublin
259,905.00
Standardisation of the Diagnostic Evaluation 
of Articulation and Phonology (DEAP) on 
Irish children, aged 3;0- 6;11 years
Dr Padraig MacNeela
Department of Psychology
NUI Galway
260,000.00
Chronic low back pain: A judgement 
analysis of GPs’ clinical judgements and 
decisions
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Programme Grants
Professor Paul McLoughlin
Human Anatomy and Physiology
University College Dublin
2951,438.40
Hypoxic lung disease
Professor Joe Duffy 
Nuclear	Medicine
University	College	Dublin
21,060,935.30
Breast	Cancer	Metastasis:	Biomarkers	and	
Functional	Mediators
Professor William Powderly
Medicine
University	College	Dublin
21,009,609
Dublin	City	HIV	Cohort
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Grant holder Title
Dr Edel Conway
Centre for Research in Management 
Learning & Development,
Dublin City University Business School
229,450.00
The impact of change on the attitudes and 
behaviour of staff in the health service: a 
longitudinal study
Dr Susan O’Shea
Department of Haematology
Cork University Hospital
Randomised Controlled Trial of Supervised 
Patient Self-Management of Warfarin Therapy 
Using an Internet Based Expert System
Sarah Jane Dillon
Research and Programmes
RehabCare
260,000.00
Rare Disabilities on the Island of Ireland 
– Investigation into the Development of an all 
Island Support Service
Dr Pauline Faughnan
Equality Studies Centre and Social Science 
Research Centre
University College Dublin
260,000.00
Empowerment for Healthy Communities:  An 
action research programme on tackling health 
inequalities in three communities through a 
community development approach
Health Services R&D Awards
Dr Sean F Dinneen
Diabetes and Endocrinology
University College Hospital Galway
21,185,245.00
Implementing and evaluating a structured 
education programme and a new model of 
ongoing for Type 1 diabetes in Ireland
Dr Fidelma Dunne
Department of Medicine/ Clinical Science 
Institute
HSE - Western Region 
21,243,428.00
Atlantic DIP: Atlantic Diabetes in 
Pregnancy Network. Prospective studies 
to examine the outcome of pregnancy in 
diabetic women
Prof John O’Leary
Department of Pathology 
Coombe’s Women’s Hospital
21,250,000.00
Working towards a world class cervical 
screening system for Irish Women: 
The Irish Cervical Screening Research 
Consortium
Prof Carol Fitzpatrick
Mater Child and Adolescent Mental Health 
Services
Mater Hospital
21,232,040.00
Adolescent Depression and Suicidal 
Behaviour - Making Knowledge Work for 
Health
Mary Fitzsimons
Epilepsy Programme
Beaumont Hospital
21,248,397.00
Revolutionising Chronic Disease 
Management with Information and 
Communication Technology : A socio-
technical project applied to epilepsy care in 
Ireland
Grant holder Title
Rare Diseases Research Awards
Dr Paul Kenna
Ocular Genetics Unit
Trinity College Dublin
2150,000.00
Exploration of exogenous microRNAs as a 
suppression tool and endogenous microR-
NAs in the context of retinal degenerations
Dr Maryanne Donovan
Biosciences Institute
University College Cork
2150,000.00
Pro-apoptotic BH3-only protein BIM and 
the regulation of photoreceptor apoptosis 
in retinal degeneration
Dr Marion Rowland
Children’s Research Centre
Our Lady’s Hospital for Sick Children
2150,000.00
The Epidemiology of Cystic Fibrosis As-
sociated Liver Disease
INFRASTRUCTURE
Equipment Grants
Professor John Scott
Department of Biochemistry
Trinity College Dublin
2106,049
Application to the Health Research Board 
for a robotic system required for intra-
mural research activities of the Health 
Research Board
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Imaging Facilities
Professor Fergal Malone
Obstetrics and Gynaecology
Royal College of Surgeons in Ireland
23,458,697
National Obstetric Ultrasound Research 
Consortium of Ireland (NOURCI)
Dr James FM Meaney
Radiology
St James’s Hospital
23,999,655
Proposal for a National Centre for Ad-
vanced Medical Imaging
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Health Information Systems Grants to underpin R&D
Dr William Gallagher
School of Bimolecular and 
Biomedical Science
University College Dublin 
2158,849.00
Digital slide management system: 
application to biomarker discovery and 
validation
Ronan Hearne
Adult Mental Health Service
Cluain Mhuire Services
239,947.00
Mental health research system 
development
Julian Pugh
Planning Commissioning and Change 
Directorate
Health Services Executive
2242,250.00
Integrated case management information 
system for drug users and related services
Professor Jane Grimson
Department of Computer Science
Trinity College Dublin 
2250,000.00
A biobank information management 
system for prostate cancer
Professor Ivan J Perry
Department Epidemiology and Public Health
Cork University Hospital
2164,319.00
A multidisciplinary application to support 
data transfer and spatial analysis of 
intentional and unintentional injuries
Professor Henry Paul Redmond
Department of Academic Surgery
Cork University Hospital
2111,500.00
A dynamic wound care database to 
facilitate interdisciplinary combined coare, 
allow furhter education of health care 
professionals and to support evidence 
based practice in the community
Grant holder
Strengthening Clinical Trials
Dr Meave Leahy
Mid Western Regional Hospital 
2360,000.00
Dr John Kennedy
St James’s Hospital
23,120,000.00
Dr Seamus O’Reilly
Cork University Hospital
2960,000.00
Dr Ray McDermot
AMNCH Tallaght Hospital
2960,000.00
Dr John McCaffrey
Mater Misericordiae
2960,000.00
Dr Paula Calvert
Waterford Regional Hospital 
2576,000.00
Dr Liam Grogan
Beaumont Hospital
2576,000.00
Dr Macon Keane
University College Hospital Galway
21,608,000.00
Dr John Crown
St Vincent’s University Hospital
2936,000.00
Prof John Armstrong
St Lukes Hospital
21,440,000.00
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CAREER DEVLOPMENT SCHEMES
Clinician Scientist Awards
Prof Mary Cannon
Department of Psychiatry
Royal College of Surgeons in Ireland
21,412,055.50
Adolescent brain development and risk 
for psychosis
Dr Joe Keane
Clinical Medicine
St James’s Hospital
21,596,683.00
Dissecting out the pathways of successful 
macrophage responses to infection with 
M. tuberculosis
PhD Training Sites
Professor Marina Lynch
Department of Physiology
Trinity College Dublin
21,000,189
From basic neuroscience to clinical 
applications: an integrated PhD programme
Dr Dermot Kelleher
Department of Clinical Medicine
Trinity College Dublin
21,074,608.60
Molecular Medicine - from genes to function
Post Doctoral Research Fellowships
Dr Steven W Kerrigan
Department of Clinical Pharmacology
Royal College of Surgeons in Ireland
2214,807.01
The influence of shear stress to investigate 
the interactions between Streptococcus 
sanguis and Staphylococcus aureus with 
perfused human blood platelets.
Dr Aedin Culhane
Bioinformatics Section
University College Dublin
2207,247.01
Application of multivariate methods to the 
analysis of a compendium of gene expression 
profiles in Leukaemia
Dr Patrick Kiely
Department of Biochemistry
University College Cork
2214,906.61
To determine the role of RACK1 and its 
IGF-1R regulated binding partners in IGF-1 
mediated metastasis and motility
Dr Aileen Houston
Medicine
University College Cork
2214,906.61
Elucidation of the molecular mechanisms 
underlying Fas ligand (FasL/CD95L) 
expression in human colon tumour cells
Dr Andrew Lindsay
Department of Biochemistry
University College Cork
2214,847.01
Characterisation of the Role of the 
Human Myosin V Family in Cell Division 
and Disease
Grant holder Title
Dr Brona Murphy
Department of Physiology and Medical Physics
Royal College of Surgeons in Ireland
2214,907.01
Investigation of death receptor signalling in 
neuronal death & neuroplastic changes 
during epilepsy development
Dr Gerard Sergeant
Regional Development Centre 
Dundalk Institute of Technology
2214,652.01
Pacemaker Activity in Urethral Interstitial 
Cells
Dr Emer Bourke
Department of Biochemistry
National University of Ireland, Galway
2214,907.01
Proteomic Definition of DNA Damage 
Response in Human Cells
Clinical Research Training Fellowships
Dr Matthew Greenway
Department of Clinical Neurosciences
Royal College of Surgeons in Ireland
2168,993.05
Hypoxia-induced Neurotrophic Factors in 
the Irish ALS Population
Dr Martina Ni Chonghaile
Department of Anaesthesia and Intensive Care
National University of Ireland, Galway
2183,612.60
Evaluation of the effects and mechanisms 
of action of Therapeutic Hypercapnic 
Acidosis in Severe Pulmonary Sepsis
Dr Tom Cawood
Department of Endocrinology
University College Dublin
2182,719.19
Potential Therapeutic Targets in Thyroid 
Associated Ophthalmopathy
Dr Eoghan O’Neill
Department of Industrial Microbiology
University College Dublin
2183,612.60
Genetic analysis of the biofilm phenotype 
in clinical isolates of methicillin-resistant 
Staphylococcus aureus
Dr Marina O Kane
Department of Biochemistry and Physiology
University College Dublin
2180,212.60
Corticotrophin-Releasing Hormone 
mediated responses in Psoriasis
Dr Catherine McVeigh
Department of Geriatric Medicine
Belfast City Hospital
2171,790.18
Is inflammation involved in the 
development of cognitive impairment or 
depression after stroke
Dr Tora Leong
Department of Cardiology
Trinity College Dublin
2110,861.60
The Role of Novel Risk Markers in 
Predicting Atherosclerosis in Patients with 
Chronic Stable Angina
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Dr John McDermott
Department of Endocrinology and 
Diabetes Mellitus
National University of Ireland, Galway
2183,612.60
Circulating endothelial progenitor cell 
number and function in progressive diabetic 
renal disease: declining in tandem with 
increasing cardiovascular risk?
Fellowships in Health Services Research
Mr Michael Rosato
Epidemiology and Public Health
Queens University Belfast
2205,307.01
Towards a better understanding of self-
reported health: a series of studies using the 
ONS-LS
Ms Emma White
Department of Mathematics
National University of Ireland, Maynooth
2130,531.46
Modelling the Drug Using Career with a 
View to Informing and Assisting Health 
Services and Policy
Dr Lisa Kelly
Departments of Neurology and Medicine 
for the Elderly
University College Dublin
2132,126.46
Dementia Following Stroke: A sub-study of 
The North Dublin Population Stroke Study
Dr Karen Ryan
Palliative Medicine
St Francis Hospice, Raheny
2128,923.21
Towards a Patient-centred and Carer-oriented 
Service: Identification of the Palliative Care 
Needs of Adults with Intellectual Disability, 
Development and Delivery of a Local 
Quality Improvement Programme
Clinical Research Fellowships in Nursing and Midwifery
Ms Patricia Larkin
School of Nursing and Midwifery
Trinity College Dublin
2204,507.01
Women’s expectations of  and preferences for 
childbirth
Ms Kate Frazer
School of Public Health and Population Science
University College Dublin
2205,157.11
An evaluation of the knowledge and attitudes 
of primary care nurses towards Hepatitis C 
Virus infection
Ms Aoife Moran
School of Nursing
Dublin City University
2135,026.46
The experience of the person with end stage 
renal disease on haemodialysis therapy
Ms Patricia Leahy Warren
The Catherine McAuley School of Nursing 
and Midwifery
University College Cork
2205,307.01
First Time Mothers: The Relationship 
Between Support, Infant Care Self-Efficacy 
and Satisfaction with Parenting
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Cochrane Fellowships
Mr Brendan Dineen
Department of General Practice
National University of Ireland, Galway
233,184.00
Laser treatment for diabetic retinopathy
Dr Clodagh Cashman
CIE Occupational Health Unit
CIE
279,346.00
Alcohol and drug screening of people whose 
work involves driving to prevent injury
Ms Genevieve Becker
National University of Ireland, Galway
267,711.00
Methods of milk expression in lactating 
women
Ms Josephine Hegarty
Faculty of Medicine and Health 
University College Cork
293,774.00
Watchful waiting versus prostatectomy for 
prostate cancer
Professor Malcolm MacLachlan
School of Psychology
Trinity College Dublin
262,456.00
Psychosocial Interventions for Physical 
Disability arising from Injury
Dr Patrick Manning
Department of Respiratory Medicine
St James’s Hospital Hospital
2121,256.00
Ciclesonide for chronic asthma in adults and 
children
NCI Summer Curriculum in Cancer
Anthony O’Grady
Department of Pathology
Royal College of Surgeons in Ireland
Molecular Prevention
Shelagh Wright
School of Nursing
Dublin City University
Molecular Prevention
Antoinette Perry
Department of Haematology
Trinity College Dublin
Molecular Prevention
Nicola Miller
Department of Surgery
St James’s Hospital
Molecular Prevention
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Juliette Sheridan
Centre for Colorectal Disease
St Vincent’s University Hospital
Molecular Prevention
Alan Coss
Centre for Colorectal Disease
St Vincent’s University Hospital
Molecular Prevention
Niamh O’Rourke
Primary, Community and Continuing Care
Health Services Executive - East Coast Area
Molecular Prevention
Fiona Quinn
Cancer Molecular Diagnostics
St James’s Hospital
Molecular Prevention
Mary-Clare Cathcart
Department of Oncology
Trinity College Dublin
Molecular Prevention
Barbara McNamara
Department of Biochemistry
St James’s Hospital
Molecular Prevention
Paul Kavanagh
Public Health Department
Health Services Executive - Southern Area
Principles and Practice of Cancer 
Prevention and Control
Marie Lavin
Department of Oncology
Mater Misericordiae University Hospital
Principles and Practice of Cancer Prevention 
and Control
Suzanne Rowley
Department of Surgery
St James’s Hospital
Principles and Practice of Cancer Prevention 
and Control
Aine McNamara
Public Health & Planning
Health Services Executive - Midlands Area
Principles and Practice of Cancer Prevention 
and Control
Ursula Bond
Department of Microbiology
Trinity College Dublin
Principles and Practice of Cancer Prevention 
and Control and Molecular Prevention
Emer O’Connell
Public Health and Epidemiology
University College Dublin
Principles and Practice of Cancer Prevention 
and Control and Molecular Prevention
Lisa O’Connor
Department of Haematology/ Oncology
St James’s Hospital
Principles and Practice of Cancer Prevention 
and Control and Molecular Prevention
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Joint Research Fellowships in Cancer
Dr Zubair Kabir
Pharmacology and Therapeutics Department 
St James’s Hospital Hospital
2158,545.00
Tobacco control policies, lung cancer and 
smoking patterns: Ireland and Massachusetts
Edward Fox 
Conway Institute of Biomolecular and 
Biomedical Research 
University College Dublin
2131,131.00
Frequency of random mutations and 
genomic instability events during colorectal 
cancer progression
Summer Students
Mr Edmond Ang
Medicine
University College Dublin
21,400
Regulation of gene expression in a clonal 
pancreatic beta-cell line
Mr Ciaran Skerry
Department of Chemistry
National University of Ireland, Maynooth
21,600
Synthesis and Anti-Microbial Screening of 
New Metal-Based Drugs
Ms Siobhan Ryan
Chemical and Life Science Dept
South Eastern Health Board
21,600
Retinal Visual Acuity in Patients with 
Age-Related Maculopathy
Ms Karen McDermott
Science
Adelaide and Meath Hospital 
(incorporating NCH)
21,200
Malnutrition in Inflammatory Bowel Disease: 
identifying patients at risk
Mr Brendan Lawless
Medicine
St Vincent’s University Hospital
21,600
Validation of Functional Transcranial 
Doppler Imaging Across Motor and 
Verbal-Production Tasks
Ms Carol Keigher
Medicine
University College Hospital, Galway
21,600
Treating to target in type 2 diabetes
Mr Alif Adlan Mohd Thabit
Medicine
Royal College of Surgeons in Ireland
21,600
Inflammatory cells in COPD and Alpha-1 
Antitrypsin deficiency
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Ms Allison Bradley
Electronic & Electrical engineering
St Vincent’s University Hospital
21,600
The influence of motor unit firing rates 
on peri-stimulus time histograms:  a 
quantitative study
Ms Irene Walsh
Biochemistry
University Dental School, Cork
21,600
Diet, oral hygiene, salivary parameters and 
dental erosion amoong dental students
Mr Harivinthan Sellappan
Faculty of Medicine
University College Dublin
21,600
The effect of partial D2 receptor agonists 
on globus pallidus GABA, glutamate and 
aspartate release in a rodent model of  
Parkinson’s disease
Ms Puspha Raman
Medicine
University College Dublin
21,600
Exploring the differences between in situ and 
invasive breast cancer
Ms Maureen Clarke
Medicine
Royal College of Surgeons in Ireland
21,200
Removing patients from a GPs list: Patient 
and Doctor perspectives
Ms Ciara O’Riordan
General Practice
National University of Ireland, Galway
21,600
General Practice Utilisation Patterns in 1124 
Mothers and Babies over the first three years 
of follow-up in Lifeways Cross-Generation 
Cohort Study.
Ms Sinead McKenna
Respiratory
St Vincent’s University Hospital
21,600
Cystic Fibrosis
Ms Ciara O’Hagan
Department of Human Anatomy and 
Physiology
University College Dublin
21,600
Influence of gender and inspiratory muscle 
training on perception of dyspnea on normal 
healthy subjects
Ms Dervla Connaughton
Student
Royal College of Surgeons in Ireland
21,600
The role of angiogenin in motoneuron 
degeneration
Mr Tonye Wilcox
Medicine
Royal College of Surgeons in Ireland
21,600
Identification of novel interactions between 
S. gordonii and human blood platelets.
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Grant holder Title
Mr Robert Scully
General Practice
National University of Ireland, Galway
21,600
What determines patients’ satisfaction with 
out of hours primary medical care?
Ms Anita Maria Sheahan
Biology Department
Trinity College Dublin
21,600
Mechanism of action of alum as a vaccine 
adjuvant
Ms Hebah Nashat
Medicine
National University of Ireland, Galway
21,600
Identification of factors responsible for 
influencing mesenchymal stem cell migration 
towards prostate cancer cells
Mr Mark Hehir
Obstetrics and gynaecology
University College Hospital, Galway
21,600
The feto-placental unit in association with 
obesity in pregnancy
Ms Sinead Kelly
Biology
National University of Ireland, Maynooth
21,600
The role of genetic polymorphism in natural 
killer cell receptors and alcohol consumption 
in susceptibility to psoriasis
Ms Gillian Murphy
Department of General Practice
National University of Ireland, Galway
21,600
A cross sectional study to describe the 
clinical impact of Ambulatory Blood Pressure 
Monitoring in routine general practice.
Mr Khaled Almansoori
Medicine
Royal College of Surgeons in Ireland
21,600
The ability of BMP-7 to promote osteogen-
esis on collagen-glycosaminoglycan scaffolds
Ms Lisa McAnena
Department of  Surgery
National University of Ireland, Galway
21,600
Evaluation of the expression and prognostic 
significance of HER1-4 in breast cancer
Ms Doireann O’Flaherty
Surgery
National University of Ireland, Galway
21,600
Characterisation of Cell Sub-Populations in 
Primary Breast Cell Culture
Ms Clare O’Sullivan
Medicine
St Vincent’s University Hospital
21,600
EEG correlates of positive and negative 
future thinking
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Grant holder Title
Ms Sarah Kandil
Neursocience
Trinity College Dublin
21,600
Are interferon gamma-primed microglia 
more responsive to amyloid-beta?
Mr David Costello
Department of Physics
Dublin Institute of Technology
21,600
Development of a novel method for 
differentiating breast lesion in diagnostic 
ultrasound images
Mr Stephen Penney
Biotechnology
University College Dublin
21,600
Effect of Plasma Treatment on Cellular 
Response
Ms Elyssa Majawit
NA
University College Dublin
21,600
The relationship between lifestyle and socio-
demographic profile at recruitment and first 
outcome follow-up through general practice 
in 2000 adult participants in the Lifeways 
Cross-generation Cohort Study
Ms Mei Ann Choong
Paediatrics, NUI, Galway
National University of Ireland, Galway
21,600
Determinants of Metabolic Control in 
Young People with Type 1 Diabetes: Audit of 
Clinical Attendees
Mr James O’Dwyer
Physiotherapy
St James’s Hospital
21,600
Validation of the RT3 activity sensor 
in patients with Chronic Obstructive 
Pulmonary Disease
Ms Sheila Sullivan
Pathology
Royal College of Surgeons in Ireland
21,600
Determination of cyclooxygenase-2 (cox-2) 
expression in bladder cancer samples from 
smokers and non-smokers.
Mr Henrik Wahlberg
Pathology
Royal College of Surgeons in Ireland
1,600
Assessment of telomerase expression levels 
in squamous cell carcinoma from both renal 
transplant and non-transplant patients
Mr Hugh Ramsay
Medicine
Royal College of Surgeons in Ireland
21,600
Antibacterial and anti-inflammatory 
properties of nicotine
Ms Annie Ngu
Medicine
University College Dublin
21,600
Prevalence of Epilepsy
Grant holder Title
Mr Dónal Tighe
Student
Mater Misericordiae Hospital
21,600
The role of net1 and myeov in colorectal 
cancer cell proliferation and invasion.
Ms Romaine King
Gastroenterology
St Vincent’s University Hospital
21,200
Bile acids and oesophageal metaplasia
Ms Cliodhna Ni Choisdealbha
Physiotherapy
East Coast Area Health Board
21,600
The relationship between physical fitness, 
physical functioning and psychological status 
in patients one year post non-acute ischaemic 
stroke.
Ms Roisin Colleran
Medicine
National University of Ireland, Galway
21,600
Viral vector delivery of oligodendrocyte 
differentiation factors to adult mesenchymal 
stem cells
Ms Audrey Melvin
Medicine
University College Dublin
21,600
Analysis of the imprinted insulin like growth 
factor 2 (IGF2), and alpha-T-catenin genes 
in transitional cell carcinoma of the bladder 
(TCCB)
Mr Michael Blake
School of Pharmacy
University College Cork
21,600
Investigation into pain control achieved by 
drug delivery to peripheral opioid receptors
Ms Jennifer Rouine
Physiology
Trinity College Dublin
21,200
Analysis of exercise-induced neurogenesis in 
the rat brain
Mr John Byrne
Student
National University of Ireland, Galway
21,600
Trancription complex formation in 
pleuripotential mesenchymal
Ms Norah Jordan
Department of Psychology
Beaumont Hospital
21,600
Factors influencing referral pathways from 
acute neurosurgical services- A systematic 
audit
Ms Lakshmi Penugonda
Clinical Pharmacology
Royal College of Surgeons in Ireland
21,600
Characterization of a novel prognostic assay 
for platelet activation in human blood
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